In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms
Open Access
- 1 February 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (2) , 328-330
- https://doi.org/10.1128/aac.31.2.328
Abstract
The in vitro activity of A-56268 was determined and compared with that of erythromycin and clindamycin against a limited spectrum of 401 gram-positive and gram-negative organisms. A-56268 was quite active against erythromycin-susceptible Staphylococcus aureus, Neisseria gonorrhoeae, Listeria monocytogenes, Streptococcus pneumoniae, Streptococcus pyogenes, and group B streptococci and was moderately active against Campylobacter fetus subsp. fetus. A-56268 was consistently bactericidal only for S. pneumoniae. The activity of A-56268 was comparable to that of erythromycin against most organisms tested.This publication has 6 references indexed in Scilit:
- Comparative in vitro activities of twelve antimicrobial agents against Campylobacter speciesAntimicrobial Agents and Chemotherapy, 1985
- Susceptibility of Legionella pneumophila to twenty antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1980
- Erythromycin: clinical review. II. Therapeutic uses.1977
- Erythromycin: clinical review I. Clinical pharmacology.1977
- Antimicrobial Activity of Several Antibiotics and a Sulfonamide Against Chlamydia trachomatis Organisms in Cell CultureAntimicrobial Agents and Chemotherapy, 1977
- SUSCEPTIBILITY OF MYCOPLASMA PNEUMONIAE TO 21 ANTIBIOTICS IN VITRO*The Lancet Healthy Longevity, 1967